I recently read about Surgient's third quarter success and about the release of their latest virtual lab automation product, VQMS. I spoke with the company's VP of Product Strategy, Erik Josowitz, to ...
Imagine you’re a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know you need the expertise of a virologist and an immunologist, plus a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback